Literature DB >> 20548043

Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT.

L H Goldstein1, T Chalder, C Chigwedere, M R Khondoker, J Moriarty, B K Toone, J D C Mellers.   

Abstract

OBJECTIVE: To compare cognitive-behavioral therapy (CBT) and standard medical care (SMC) as treatments for psychogenic nonepileptic seizures (PNES).
METHODS: Our randomized controlled trial (RCT) compared CBT with SMC in an outpatient neuropsychiatric setting. Sixty-six PNES patients were randomized to either CBT (plus SMC) or SMC alone, scheduled to occur over 4 months. PNES diagnosis was established by video-EEG telemetry for most patients. Exclusion criteria included comorbid history of epilepsy, <2 PNES/month, and IQ <70. The primary outcome was seizure frequency at end of treatment and at 6-month follow-up. Secondary outcomes included 3 months of seizure freedom at 6-month follow-up, measures of psychosocial functioning, health service use, and employment.
RESULTS: In an intention-to-treat analysis, seizure reduction following CBT was superior at treatment end (group x time interaction p < 0.0001; large to medium effect sizes). At follow-up, the CBT group tended to be more likely to have experienced 3 months of seizure freedom (odds ratio 3.125, p = 0.086). Both groups improved in some health service use measures and on the Work and Social Adjustment Scale. Mood and employment status showed no change.
CONCLUSIONS: Our findings suggest that cognitive-behavioral therapy is more effective than standard medical care alone in reducing seizure frequency in PNES patients. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that CBT in addition to SMC, as compared to SMC alone, significantly reduces seizure frequency in patients with PNES (change in median monthly seizure frequency: baseline to 6 months follow-up, CBT group, 12 to 1.5; SMC alone group, 8 to 5).

Entities:  

Mesh:

Year:  2010        PMID: 20548043      PMCID: PMC2905892          DOI: 10.1212/WNL.0b013e3181e39658

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

Review 2.  Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials.

Authors:  K Kroenke; R Swindle
Journal:  Psychother Psychosom       Date:  2000 Jul-Aug       Impact factor: 17.659

3.  Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

Authors:  Isabelle Boutron; David Moher; Douglas G Altman; Kenneth F Schulz; Philippe Ravaud
Journal:  Ann Intern Med       Date:  2008-02-19       Impact factor: 25.391

4.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 5.  The approach to patients with "non-epileptic seizures".

Authors:  J D C Mellers
Journal:  Postgrad Med J       Date:  2005-08       Impact factor: 2.401

6.  Normative data for the HADS from a large non-clinical sample.

Authors:  J R Crawford; J D Henry; C Crombie; E P Taylor
Journal:  Br J Clin Psychol       Date:  2001-11

7.  What is "treatment as usual" for nonepileptic seizures?

Authors:  W Curt LaFrance; Mark D Rusch; Jason T Machan
Journal:  Epilepsy Behav       Date:  2008-02-20       Impact factor: 2.937

8.  An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study.

Authors:  Laura H Goldstein; Alicia C Deale; Sara J Mitchell-O'Malley; Brian K Toone; John D C Mellers
Journal:  Cogn Behav Neurol       Date:  2004-03       Impact factor: 1.600

9.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

Review 10.  The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review.

Authors:  V Deary; T Chalder; M Sharpe
Journal:  Clin Psychol Rev       Date:  2007-07-17
View more
  69 in total

Review 1.  Psychogenic Non-Epileptic Seizures.

Authors:  David K Chen; Esha Sharma; W Curt LaFrance
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

Review 2.  Functional neurological disorders: mechanisms and treatment.

Authors:  Alexander Lehn; Jeannette Gelauff; Ingrid Hoeritzauer; Lea Ludwig; Laura McWhirter; Stevie Williams; Paula Gardiner; Alan Carson; Jon Stone
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

3.  Diagnostic delay in psychogenic seizures and the association with anti-seizure medication trials.

Authors:  Wesley T Kerr; Emily A Janio; Justine M Le; Jessica M Hori; Akash B Patel; Norma L Gallardo; Janar Bauirjan; Andrea M Chau; Shannon R D'Ambrosio; Andrew Y Cho; Jerome Engel; Mark S Cohen; John M Stern
Journal:  Seizure       Date:  2016-06-23       Impact factor: 3.184

Review 4.  Functional (psychogenic) movement disorders.

Authors:  Kathrin Czarnecki; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

Review 5.  Ethical dilemmas in pediatric and adolescent psychogenic nonepileptic seizures.

Authors:  Cristie M Cole; Tatiana Falcone; Rochelle Caplan; Jane Timmons-Mitchell; Kristine Jares; Paul J Ford
Journal:  Epilepsy Behav       Date:  2014-07-10       Impact factor: 2.937

6.  Neuropsychiatric disorders: What do neurologists think about conversion disorder?

Authors:  Joseph H Friedman
Journal:  Nat Rev Neurol       Date:  2011-05-17       Impact factor: 42.937

7.  Neglected patients, few treatments, and minimal evidence: the updated cochrane review on psychological and behavioral treatments for nonepileptic seizures.

Authors:  Barbara A Dworetzky
Journal:  Epilepsy Curr       Date:  2014 Nov-Dec       Impact factor: 7.500

8.  Treatment Challenges in Nonepileptic Psychogenic Seizures: Finding the Perfect Fit for the No-One-Size-Fits-All Group.

Authors:  Roy Martin
Journal:  Epilepsy Curr       Date:  2017 May-Jun       Impact factor: 7.500

Review 9.  Conversion Disorder, Functional Neurological Symptom Disorder, and Chronic Pain: Comorbidity, Assessment, and Treatment.

Authors:  Patricia Tsui; Andrew Deptula; Derek Y Yuan
Journal:  Curr Pain Headache Rep       Date:  2017-06

10.  The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause.

Authors:  Antonella Bruni; Iolanda Martino; Giuseppe Borzì; Antonio Gambardella; Pasquale De Fazio; Angelo Labate
Journal:  Neurol Sci       Date:  2017-02-15       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.